P13.05 Real-World Treatment Patterns and Sequencing of Immunotherapy and Chemotherapy Based on PD-L1 TPS in European Patients With mNSCLC

Journal of Thoracic Oncology(2021)

引用 0|浏览7
暂无评分
摘要
We evaluated a large real-world dataset across EU5 countries (UK, Germany, France, Italy, Spain) for use of immunotherapy and chemotherapy in clinical practice during a time of evolving treatment landscape in metastatic non-small cell lung cancer (NSCLC), based on PD-L1 tumor proportion score (TPS).
更多
查看译文
关键词
immunotherapy,chemotherapy,real-world
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要